Abstract
The stability and stoichiometry of β3-peptide bundles is influenced by side-chain identity. β3-peptides containing β3-homoleucine on one helical face assemble into octamers, whereas those containing β3-homovaline form tetramers. From a structural perspective, the side chains of β3-homoleucine and β3-homovaline differ in terms of both side-chain length and γ-carbon branching. To evaluate the extent to which these two parameters control β3-peptide bundle stoichiometry, we synthesized the β3-peptide Acid-3Y, which contains β3-homoisoleucine in place of β3-homoleucine or β3-homovaline. Acid-3Y assembles into a stable tetramer whose stability resembles that of the previously characterized Acid-VY tetramer. These results suggest that β3-peptide bundle stoichiometry is dominated by the presence or absence of γ-carbon branching on core side chains.
Keywords: Biomaterial, Protein design, Protein folding, Self-assembly
1. Introduction
We previously reported that certain β3-peptides self-assemble spontaneously in aqueous solution into discrete, octameric bundles whose kinetic and thermodynamic metrics resemble those of natural proteins.1–5 The β3-peptide bundles we described undergo cooperative, two-state folding transitions, exchange core amide protons slowly, and exclude hydrophobic dyes; the structures of five such bundles are known in atomic detail.1,2,5,6 These initially reported octameric assemblies were designed without the benefit of high-resolution structural data, and were expected to assemble as dimers or tetramers. The observation of a discrete octameric array, with a hydrophobic core composed entirely of solvent-inaccessible β3-homoleucine residues, was unanticipated. The structures now available provide the opportunity to study and evaluate the relationship between core residue identity and bundle stoichiometry, kinetic stability, thermodynamic stability, and the cooperativity of unfolding.
It is well known that the stability and stoichiometry of helical bundle proteins found in nature is influenced by the identities of residues found at the a and d positions of the heptad repeat.7 In complexes characterized by parallel, dimeric coiled coils (such as those in bZIP proteins), these positions are often occupied by leucine residues.8,9 Substitution of core leucines in the bZIP protein GCN4 for valine or isoleucine results in three-and four-helix bundles that differ from the dimeric wildtype.8 In addition to the effect on bundle stoichiometry, the identities of residues at core positions can also affect the relative orientation of helices; both parallel and antiparallel coiled coils are known.10 For example, certain GCN4 variants form a tetrameric bundle consisting of parallel helices, in contrast to the antiparallel conformation in most well-characterized four-helix bundles.8
The stability and stoichiometry of β3-peptide bundles is likewise influenced by side-chain identity. Although β3-peptides containing β3-homoleucine at the four core positions (indicated by X in Fig. 1a) assemble into octameric bundles, those containing β3-homovaline at these positions assemble into tetramers (Fig. 1a).4 At the constitutional level, β3-homovaline and β3-homoleucine differ not only by the presence or absence of a methylene group but also by the extent of branching at the γ-carbon (Fig. 1b). To evaluate the relative contribution of these two parameters to β3-peptide bundle stoichiometry, we synthesized the β3-peptide Acid-3Y, which is analogous to Acid-1Y and Acid-VY in every respect except for the inclusion of β3-homoisoleucine–which is γ-branched but isomeric with β3-homoleucine–at all four core positions. Here we report that Acid-3Y assembles into a stable tetramer in solution whose thermodynamic metrics are virtually identical to that of the previously reported Acid-VY tetramer.4 These results suggest that β3-peptide bundle stoichiometry is controlled in full or in part by the presence or absence of branching at the γ-carbon.
Fig. 1.
(a) Helical net and linear representations of β3-peptides discussed in this work and (b) comparison between β3-hLeu, β3-hVal and β3-hIle side chains. Letters represent standard amino acid abbreviations; O = ornithine.
2. Results and discussion
To determine whether Acid-3Y assembled into a bundle with discrete stoichiometry, we first performed sedimentation equilibrium analytical ultracentrifugation (SE-AU) experiments at concentrations of 27.5 µM, 137.5 µM and 275 µM (Fig. 2).
Fig. 2.
Self-association of Acid-3Y monitored by sedimentation equilibrium analytical ultracentrifugation (SE-AU) and fit to a monomer-n-mer equilibrium model. Results are shown for [Acid-3Y] = 27.5 µM. Data points are represented as open circles with colors corresponding to the indicated speeds. Black lines indicate fits to (a) n = 4; (b) n = 3; (c) n = 5; and (d) n = 8 models.
The AU data fit best to a two-state monomer-n-mer equilibrium model. Minimizing the RMSD of the fit as a function of all n returned n = 4.37 with an RMSD of 0.00761. Setting n = 4 resulted in a comparable fit with an RMSD of 0.00968 (Fig. 2a). Holding the value of n constant to model other potential integer stoichiometries between 2 and 8 resulted in poorer fits with higher RMSD values (0.02675, 0.01115, 0.03172 for n = 3, 5 and 8 respectively) and residuals with systematic errors (Fig. 2b–d). These results are consistent with a tetrameric stoichiometry for the Acid-3Y bundle. The ln Ka value for Acid-3Y derived from the tetramer fit is 40.9 ± 1.5 (Ka = 5.79 × 1017 M−3), a value close to the ln Ka values of 38.2 ± 0.8 and 35.1 ± 0.8 (Ka = 3.89 × 1016 M−3 and 1.75 × 1015 M−3) reported for the tetrameric bundles formed from Zwit-VY and Acid-VY, respectively, which each possess β3-homovaline at all four core positions.4 Although the data acquired at 137.5 µM Acid-3Y fit best to a model in which n = 4.93, this deviation from a tetramer model is most likely a numerical bias at that particular concentration; the data acquired at 27.5 µM and 275 µM Acid-3Y fit best to models in which n = 4.35 and 4.40 respectively, corresponding closely to the n = 4.37 obtained from the global fit. Overall, the AU data suggest that Acid-3Y exists as a predominantly tetrameric species in solution, although we cannot rule out the contribution of higher order species.
We next used wavelength-dependent circular dichroism (CD) spectroscopy to characterize concentration and temperature-dependent changes in the Acid-3Y secondary structure and provide further evidence for the tetrameric stoichiometry suggested by the SE-AU data (Fig. 3a–c). Acid-3Y underwent a concentration-dependent increase in 314-helical structure (as judged by the molar residue ellipticity at 212 nm, MRE212) between 20 and 100 µM (Fig. 3a). This behavior is characteristic of a concentration-dependent equilibrium between a partially structured monomer and a folded oligomer, and mimics the behavior of previously characterized β3-peptide bundles, whether octameric (Zwit-1F, Zwit-8L*, Acid-1Y, Zwit-EYYK, Acid-1YLL, Acid-1YLL*)1,2,5,6 or tetrameric (Zwit-VY and Acid-VY).4 A plot of MRE212 as a function of Acid-3Y concentration fit to a monomer-tetramer equilibrium model with ln Ka = 35.7 ± 0.8 (Fig. 3b), in reasonable agreement with the value calculated from the AU data (ln Ka = 40.9 ± 1.5).11
Fig. 3.
Biophysical characterization of the Acid-3Y bundle. (a) Wavelength-dependent circular dichroism (CD) spectra of Acid-3Y at concentrations between 20 and 100 µM; (B) Plot of MRE212 versus [Acid-3Y] fit to an ideal monomer-tetramer equilibrium (red line); (C) Plot of δMRE/δT as a function of T for five different concentrations of Acid-3Y; (D) Ratio of ANS fluorescence (I/I0) in the presence of the indicated concentration of Acid-1Y (octamer), Acid-VY (tetramer) and Acid-3Y (tetramer). The concentration of ANS was 10 µM.
In addition, the temperature dependent CD spectra of Acid-3Y showed a concentration-dependent increase in Tm, which further suggests self-association (Fig. 3c). The Tm (defined as the maximum in a plot of δMRE212•δT−1) of Acid-3Y at concentrations of 6.25 µM (63% folded), 12.5 µM (69% folded) and 25 µM (80% folded) peptide are 73°C, 82°C and 85°C respectively. These values reflect a thermal stability similar to that of Acid-VY, which at 80 µM concentration (88% folded) has a Tm of 85°C.4 Both Acid-3Y and Acid-VY appear more stable than Acid-1Y, which at 100 µM concentration (92% folded) exhibits a Tm of 79°C.2 Taken together, the CD and SE-AU data indicate that Acid-3Y assembles into a thermally stable tetrameric β3-peptide bundle.
We carried out 1-anilino-8-naphthalenesulfonate (ANS) binding experiments to further characterize the hydrophobic packing in Acid-3Y bundles. The fluorescence of ANS increases in a hydrophobic environment, making it a useful probe of access to a protein core. Most well-folded proteins possess a solvent-sequestered core; they bind ANS poorly and do not cause a significant increase in fluorescence.12 Molten globules, such as α-lactalbumin, bind ANS well, resulting in changes in fluorescence between 60- and 100-fold.13 The fluorescence increase of 10 µM ANS in the presence of 25 µM Acid-3Y (80% tetramer) relative to ANS alone was 1.3-fold; this value increased only to 2.8-fold in the presence of 400 µM Acid-3Y (100% tetramer, Figure 3D). The increased fluorescence of ANS upon addition of Acid-VY ranged similarly from 1.1-fold at 25 µM (91% tetramer) to 1.2-fold at 300 µM (98% tetramer). The analogous values for the octameric Acid-1Y bundle were 1.1-fold (25 µM peptide, 74% octamer) and 1.6-fold (400 µM peptide, 98% octamer). Although these changes in ANS fluorescence are measurable, the values are small, suggesting low accessibility of the tetramer hydrophobic surface. This minimal concentration-dependent increase in ANS fluorescence upon addition of Acid-3Y suggests that it, like all previously reported bundles, possesses a minimally exposed hydrophobic core.
3. Conclusion
In this work we have shown that the β3-peptide Acid-3Y, which contains four β3-homoisoleucine residues on one 314-helical face, assembles in aqueous solution into a well-folded, tetrameric bundle. The stability of this bundle, as judged by SE-AU, CD and ANS binding, is virtually identical to that formed by analogous β3-peptides containing β3-homovaline in place of β3-homoisoleucine.4 By comparison, analogous peptides containing a β3-homoleucine face assemble into octameric bundles, irrespective of side chain identity at most other positions. The difference in oligomeric states between peptides containing β3-homoleucine and β3-homoisoleucine might initially be surprising, as leucine and isoleucine possess the same molecular weight, and similar van der Waals surface areas and hydrophobic indices at neutral pH.14 β3-homoisoleucine, however, is predicted by molecular mechanics calculations to possess only one favorable rotamer (g−) in the context of a 314-helix, due to torsional restraints imposed by branching at the γ-carbon.15 β3-homovaline is also branched at the γ-carbon, and this conformational restraint may guide packing in the hydrophobic core of β3-peptide bundles, leading to a preference for tetrameric stoichiometry.
In the absence of structural information, it is not possible to directly compare the packing arrangements and preferences in the hydrophobic cores of α-peptide and β-peptide bundles. Nevertheless, the observation that replacing leucine with isoleucine in both cases leads to a change in association state highlights the role of side-chain connectivity in dictating bundle stoichiometry. Understanding the effects of side-chain regio- and stereochemistry in both natural and unnatural self-associating systems is a significant challenge for the field of foldamer design.
In summary, the experiments presented herein compelling evidence that substitution at the γ-carbon of a hydrophobic β3-amino acid residue plays an important role in defining bundle stoichiometry. Future work will include efforts towards obtaining a high-resolution structure of Acid-3Y and Acid-VY, which will allow us to explore the influence of core residue identity on strand orientation preferences (parallel vs. antiparallel) in tetrameric bundles and help illuminate how the growing collection of protein-like β-peptide bundles might be exploited for higher order functionality.
4. Experimental section
4.1 General methods
Fmoc-protected α-amino acids and Wang resin were purchased from Novabiochem (San Diego, CA). (7-azabenzotriazol-1-yloxy) tripyrrolidinophosphonium hexafluorophosphate (PyAOP) and 1-hydroxy-7-azabenzotriazole (HOAt) were purchased from ChemPep (Wellington, FL) and Oakwood Products (West Columbia, SC). Dimethylformamide (DMF), N-methyl morpholine (NMM), trifluoroacetic acid (TFA) and piperidine were purchased from American Bioanalytical (Natick, MA). All other reagents were purchased from Sigma-Aldrich. β3-peptides were synthesized with a MARS Microwave Assisted Reaction System (CEM corp., Matthews, NC). Mass spectra were acquired with an Applied Biosystems Voyager-DE Pro MALDI-TOF mass spectrometer (Foster City, CA). Reversed-phase HPLC was performed using a Varian Prostar HPLC and Vydac semi-preparative (C8, 300 Å, 5 µm, 25 mm × 250 mm) or analytical (C8, 300 Å, 5 µm, 4.6 mm × 150 mm) columns, using water/acetonitrile gradients containing 0.1% TFA. Circular dichroism (CD) spectra were acquired with a Jasco J-810 Spectropolarimeter (Tokyo, Japan) equipped with a Peltier temperature control. Analytical ultracentrifugation (AU) was performed using a Beckman XL-I instrument (Fullerton, CA). 1H NMR experiments were performed on a Bruker 500 MHz instrument. All CD, AU and ANS binding experiments were performed in buffer A (10 mM NaH2PO4, 200 mM NaCl, pH 7.1).
4.2 β3-peptide preparation
Fmoc-protected β3-amino acids were synthesized according to methods described by D. Seebach.16 Acid-3Y was synthesized on a 25 µmole scale using standard Fmoc solid-phase chemistry and Wang resin loaded with β3-homoaspartic acid as previously described.17 One cycle of peptide elongation consisted of two deprotection steps and one coupling step. Fmoc removal was performed first with 20% piperidine in DMF (50% power at 400 W maximum, 70°C, ramp 2 min, hold 4 min) followed by 2% 1, 8-diazabicyclo[5.4.0]undec-7-ene (DBU) in DMF (50% power at 400 W maximum, 40°C, ramp 2 min, hold 2 min). Coupling reactions were performed using 3 equiv. Fmoc-β3-amino acid, PyAOP and HOAt and 8 equiv. diisopropylethylamine (DIEA) in DMF (50% power at 400 W maximum, 60°C, ramp 2 min, hold 6 min). The resin was washed extensively with DMF in between each step. Once the β3-peptide sequence was complete, the resin was subjected to a final round of deprotection, washed extensively with DMF followed by methanol, then dried overnight under nitrogen. Cleavage of the peptide from resin was performed with a cocktail containing 2.5% each of 3,6-Dioxa-1,8-octanedithiol, triisopropylsilane and water in TFA (50% power at 400 W maximum, 38°C, ramp 2 min, hold 30 min). The cleavage cocktail was removed by rotary evaporation and the peptide was dissolved in 20% acetonitrile in water, and lyophilized before purification by HPLC. Semi-preparative HPLC was performed using a linear gradient of 20% to 80% acetonitrile in water containing 0.1% TFA.
Purity and identity of the peptide were assessed using both analytical HPLC and MALDI-TOF. Mass spectra were obtained using peptide samples in a α-cyano-4-hydroxycinnamic acid (CHCA) matrix. The purified peptide was then lyophilized and reconstituted in buffer A for subsequent characterization.
4.3 Sedimentation equilibrium analytical ultracentrifugation
Pure lyophilized Acid-3Y was resuspended in buffer A at three different concentrations (275 µM, 137.5 µM and 27.5 µM) and allowed to reach sedimentation equilibrium in an analytical ultracentrifuge at 4 different speeds (60, 50, 42, and 36 krpm). Centrifugation was performed in an AN 60-Ti 4-hole rotor equipped with six-channel, carbon-epoxy composite centerpieces (Beckman, Fullerton, CA). Absorbance was monitored at 280 nm for samples at 275 µM and 137.5 µM concentration, and at 230 nm for samples at 27.5 µM. Data were collected with a step size of 0.001 cm with scans occurring at 3 hour intervals. Samples were determined to be at equilibrium when no significant changes in radial concentration were observed in 3 successive scans as determined by the program Match within the HeteroAnalysis software suite (available from http://vm.uconn.edu~wwwbiotc/uaf.html).
Data were fit to a monomer-n-mer equilibrium model using the software HeteroAnalysis (see above for reference). Fixed parameters were as follows: MWmonomer = 1682 Da; v-bar = 0.7876 cm3/g (calculated according to Durchshlag and Zipper18); d = 1.00674 g/ml; ε280 = 2520 cm−1M−1; ε230 = 9680 cm−1M−1 and n = 4. Fitted parameters were as follows: ln Ka = 40.9 ± 1.5; RMSD = 0.00968 and baseline deviation <0.02.
4.4 Circular dichroism spectroscopy
Wavelength-dependent CD spectra were obtained in triplicate for concentrations of Acid-3Y ranging from 20 µM to 300 µM at 25°C in continuous scan mode with data pitch = 0.5 nm, scanning speed = 50 nm/min, response time = 4 s, band width = 0.5 nm and 3 accumulations. The concentration dependence of MREmin was determined by least-squares fitting of the total peptide monomer concentration as a function of experimental MRE using the equation below in Kaleidagraph (Synergy Software, Reading, PA).19 Fixed parameters were MREMon = 0 deg• cm2•dmol−1 and n = 4.
Temperature-dependent CD spectra were taken by monitoring the change in MRE at 212 nm between 5°C and 95°C, using the variable temperature module provided with the instrument, with data pitch = 1°C, delay time = 5 s, temperature slope = 1°C/min, response time = 4 s and band width = 1 nm. The first derivatives of the temperature-dependent CD spectra for various concentrations of Acid-3Y were computed and the Tm values correspond to the temperatures at which maximum δMRE/δT occur.
4.5 ANS binding studies
Stock solutions of 800, 400, 200, 100, 50, 25, and 12.5 µM Acid-3Y and 20 µM ANS were prepared by serial dilution in buffer A. The peptide solutions were then mixed with the stock ANS solution at a 1:1 ratio (80 µl of each) to give final concentrations of 400, 200, 100, 50, 25, 12.5 and 6.25 µM Acid-3Y and 10 µM ANS. Fluorescence intensity (counts/s) measurements were made using a Photon Technology International (Lawrenceville, NJ) Quantamaster C-60 spectrofluorimeter at 25°C in a 1 cm path length quartz cuvette. The samples were excited with 350 nm light (4 nm slit width) and fluorescence emission was measured at 1 nm intervals between 400 and 600 nm. I/I0 was calculated by dividing the maximum ANS fluorescence intensity at each concentration of peptide (I) by the fluorescence intensity in the absence of peptide (I0).
Acknowledgments
This work was supported by the NIH (GM 74756) and the NSF (CHE-0848098).
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References and notes
- 1.Daniels DS, Petersson EJ, Qiu JX, Schepartz A. J. Am. Chem. Soc. 2007;129:1532–1533. doi: 10.1021/ja068678n. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Goodman JL, Petersson EJ, Daniels DS, Qiu JX, Schepartz A. J. Am. Chem. Soc. 2007;129:14746–14751. doi: 10.1021/ja0754002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Petersson EJ, Craig CJ, Daniels DS, Qiu JX, Schepartz A. J. Am. Chem. Soc. 2007;129:5344–5345. doi: 10.1021/ja070567g. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Goodman JL, Molski MA, Qiu J, Schepartz A. ChemBioChem. 2008;9:1576–1578. doi: 10.1002/cbic.200800039. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Craig CJ, Goodman JL, Schepartz A. ChemBioChem. 2011;12:1035–1038. doi: 10.1002/cbic.201000753. [DOI] [PubMed] [Google Scholar]
- 6.Molski MA, Goodman JL, Craig CJ, Meng H, Kumar K, Schepartz A. J. Am. Chem. Soc. 2010;132:3658–3659. doi: 10.1021/ja910903c. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Cohen C, Parry DAD. Proteins. 1990;7:1–15. doi: 10.1002/prot.340070102. [DOI] [PubMed] [Google Scholar]
- 8.Harbury PB, Zhang T, Kim PS, Alber T. Science. 1993;262:1401–1407. doi: 10.1126/science.8248779. [DOI] [PubMed] [Google Scholar]
- 9.Neuberg M, Schuermann M, Hunter JB, Muller R. Nature. 1989;338:589–590. doi: 10.1038/338589a0. [DOI] [PubMed] [Google Scholar]
- 10.Oakley MG, Hollenbeck J. Curr. Opin. Struc. Biol. 2001;11:450–457. doi: 10.1016/s0959-440x(00)00232-3. [DOI] [PubMed] [Google Scholar]
- 11.Although we cannot account for the small discrepancy between the ln Ka values obtained from AU and CD data, it is worth noting that the two techniques generated a similar discrepancy in the association constants for Acid-VY.
- 12.Matulis D, Baumann CG, Bloomfield VA, Lovrien RE. Biopolymers. 1999;49:451–458. doi: 10.1002/(SICI)1097-0282(199905)49:6<451::AID-BIP3>3.0.CO;2-6. [DOI] [PubMed] [Google Scholar]
- 13.Semisotnov GV, Rodionova NA, Razgulyaev OI, Uversky VN, Gripas AF, Gilmanshin RI. Biopolymers. 1991;31:119–128. doi: 10.1002/bip.360310111. [DOI] [PubMed] [Google Scholar]
- 14.Monera OD, Sereda TJ, Zhou NE, Kay CM, Hodges RS. J. Peptide Sci. 1995;1:319–329. doi: 10.1002/psc.310010507. [DOI] [PubMed] [Google Scholar]
- 15.Shandler SJ, Shapovalov MV, Dunbrack RL, Jr, DeGrado WF. J. Am. Chem. Soc. 2010;132:7312–7320. doi: 10.1021/ja906700x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Seebach D, Overhand M, Kulnle FNM, Martinoni B, Oberer L, Hommel U, Widmer H. Helv. Chim. Acta. 1996;79:913–941. [Google Scholar]
- 17.Kritzer JA, Tirado-Rives J, Hart SA, Lear JD, Jorgensen WL, Schepartz A. J. Am. Chem. Soc. 2005;127:167–178. doi: 10.1021/ja0459375. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Durchschlag H, Zipper P. Prog. Coll. Pol. Sci. 1994;94:20–39. [Google Scholar]
- 19.DeGrado WF, Lear JD. J. Am. Chem. Soc. 1985;107:7684–7689. [Google Scholar]



